Rollins Inc. Common Stock vs Veeva Systems — how do they compare? Rollins Inc. Common Stock trades at $32.61 (market cap $15.47B), while Veeva Systems trades at $297 (market cap $48.84B). The key difference: Veeva Systems is far larger — about 3.2× Rollins Inc. Common Stock's market cap, and Rollins Inc. Common Stock pays a 2.27% dividend while Veeva Systems pays none. Which is the better fit depends on your goals — on Pluang, investors hold Rollins Inc. Common Stock for 0 Days and Veeva Systems for 6 Days on average.
| ROL | VEEV | |
|---|---|---|
Market Cap | $15.47B | $48.84B |
Volume | 6,712,154 | 2,253,175 |
Sector | Industrials | Technology |
52-Week High | $65.60 | $301.63 |
52-Week Low | $29.69 | $151.43 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $16.48B | $41.75B |
Dividend Yield | 2.27% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Veeva Systems (VEEV) trades at $301.63, up 1.95% with strong technical momentum and bullish moving averages. The company demonstrates robust fundamentals with 74.96% gross margins and consistent earnings beats, while expanding partnerships with IQVIA and Servier enhance growth prospects. Recent news highlights AI innovations and increasing adoption among biotech firms, supporting positive sentiment.
Outlook remains favorable with analyst consensus at Buy (67% rating) and $290.50 price target, though valuation multiples appear elevated. Key risks include market saturation concerns and potential volatility from RSI overbought signals. The stock's proximity to 52-week highs suggests continued investor confidence in Veeva's life sciences software leadership.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Rollins Inc. provides pest control services to residential and commercial customers through its family of brands, including Orkin, across dozens of countries.
Read more on ROL →Veeva Systems provides cloud software, data, and services for the life sciences industry. Its applications support functions across clinical research, regulatory operations, quality, safety, and commercial teams.
Read more on VEEV →